Express Pharma

Provention Bio diabetes drug to cost $13,850/vial

The US Food and Drug Administration (FDA) approved use of the drug, to be sold under brand name Tzield, for delaying the onset of insulin-dependent type-I diabetes, which is less common than type-II of the disease, for people aged eight years and above

0 383